AI Summary
✦ ClarthaNiva Bupa is an Indian health insurance company serving retail, travel, and corporate customers. Retail plans for individuals, families, seniors, NRIs, critical illness, maternity, and accidents drive the core franchise. Travel policies and corporate group health, personal accident, and OPD coverage add premium sources. Q1 2027 commentary focused on retail, but the provided update does not quantify its margin or growth effect. Revenue grew 24.9% year-on-year, while profit fell 38.8%; stable margins suggest earnings pressure likely reflects factors outside operating margin. ROE stands at 12.1%, with debt-to-equity unavailable, limiting leverage assessment. At 81.3 times earnings, valuation is rich versus current profit growth and appears overvalued. The key investor question is whether retail expansion can convert premium growth into faster profit growth.
Price Forecast
Probabilistic Range
Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.
Revenue Forecast
₹ CrEPS Forecast
₹ / shareMulti-factor synthesis of 5 key dimensions
From 10 analysts
Fundamentals
Fundamentals institutional score is 69 using EVA spread proxy 0.1%; growth durability 97.3.
Valuation
Valuation institutional score is 76 using relative multiple z-scores where peer dispersion is available.
Analyst Consensus
Analyst View institutional score is 75 using mean target upside 17.0%; dispersion penalty 6.0; recommendation breadth from available consensus.
Technical Structure
Technicals institutional score is 85 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.
Market Sentiment
Recent news flow is balanced or not decisive enough to tilt the tape. Based on 2 recent ticker-linked news items.
Signal Summary
Market intelligence remains Neutral. fundamentals and valuation provide support, while market sentiment remain considerations.
Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.
Key Data Points
Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.
Valuation Metrics
Trading 8.4% above historical median. Valuation is stable — currently in the strongly overvalued zone (z-score: +1.21). Confidence: 93%.
Live forward EPS implies next-12-month EPS of ₹3.39. Applying the stock's normalized valuation corridor produces a fair range of ₹241.33 to ₹267.20, with base value near ₹254.39 (+194.5% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹3.39
Forward P/E
25.5x
Base Fair Value
₹254.39
Fair Range
₹241.33 - ₹267.20
Upside To Base
+194.5%
Estimate Source
Live forward EPS
5Y Average
4.88
Current
4.14
Overvalued
5.61
Undervalued
4.15
5Y Average
75.99
Current
81.31
Overvalued
78.82
Undervalued
71.19
5Y Average
1.66
Current
1.78
Overvalued
1.91
Undervalued
1.41
Peers & Comparison
Sector: Financials · Theme: Insurance
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
MAX FINANCIAL SERV LTD MFSLInsurance | -40.2% | 0.2% | 623.0x Premium | +459% vs avg | -5.7% |
GO DIGIT GENERAL INS LTD GODIGITInsurance | +8.6% | 4.8% | 49.7x Undervalued | -55% vs avg | -24.7% |
THE NEW INDIA ASSU CO LTD NIACLInsurance | +1.5% | 1.5% | 37.8x Undervalued | -66% vs avg | -2.8% |
ICICI PRU LIFE INS CO LTD ICICIPRULIInsurance | -83.1% | 2.6% | 42.7x Undervalued | -62% vs avg | -18.8% |
STAR HEALTH & AL INS CO L STARHEALTHInsurance | +1407.8% | 3.6% | 50.2x Undervalued | -55% vs avg | +29.2% |
GENERAL INS CORP OF INDIA GICREInsurance | -1.3% | 18.3% | 6.5x Undervalued | -94% vs avg | -10.5% |
DABUR INDIA LTD DABURFMCG - Personal Products | +10.6% | 14.6% | 36.7x Undervalued | -67% vs avg | -17.6% |
EXIDE INDUSTRIES LTD EXIDEINDBatteries | +17.7% | 4.9% | 44.5x Undervalued | -60% vs avg | +29.0% |
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
MAX FINANCIAL SERV LTD MFSLInsurance | -40.2% | 0.2% | 623.0x Premium | +374% vs avg | -5.7% |
GO DIGIT GENERAL INS LTD GODIGITInsurance | +8.6% | 4.8% | 49.7x Undervalued | -62% vs avg | -24.7% |
THE NEW INDIA ASSU CO LTD NIACLInsurance | +1.5% | 1.5% | 37.8x Undervalued | -71% vs avg | -2.8% |
ICICI PRU LIFE INS CO LTD ICICIPRULIInsurance | -83.1% | 2.6% | 42.7x Undervalued | -68% vs avg | -18.8% |
STAR HEALTH & AL INS CO L STARHEALTHInsurance | +1407.8% | 3.6% | 50.2x Undervalued | -62% vs avg | +29.2% |
GENERAL INS CORP OF INDIA GICREInsurance | -1.3% | 18.3% | 6.5x Undervalued | -95% vs avg | -10.5% |
CANARA HSBC LIFE INS CO L CANHLIFEInsurance | +20.4% | 1.1% | 109.8x Undervalued | -16% vs avg | +36.6% |
NIVA BUPA HEALTH INS CO L trades at a discount (80.3x vs peer avg 111.4x), suggesting potential undervaluation relative to the Insurance cohort. Peers include MAX FINANCIAL SERV LTD, GO DIGIT GENERAL INS LTD, THE NEW INDIA ASSU CO LTD — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹2.47K CrJun 2026Latest net profit
₹138 CrJun 2026Latest EPS
₹0.75Jun 2026Net margin
7.0%Jun 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Jun 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 969 | 1,026 | 1,316 | 1,124 | 1,321 | 1,258 | 1,671 | 1,932 | 1,574 | 1,611 | 2,251 | 2,471 |
| Expenses + | 1,027 | 1,071 | 1,215 | 1,228 | 1,387 | 1,282 | 1,420 | 1,834 | 1,627 | 1,705 | 2,069 | 2,287 |
| Operating Profit | -58 | -46 | 100 | -103 | -66 | -24 | 251 | 98 | -53 | -94 | 182 | 184 |
| OPM % | -6% | -4.4% | 8% | -9% | -5.0% | -1.9% | 15% | 5% | -3.4% | -6% | 8% | 7% |
| Other Income + | 50 | 50 | 57 | 84 | 79 | 37 | -45 | -0 | 18 | 7 | -1 | -0 |
| Interest | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Depreciation | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Profit before tax | -8 | 5 | 157 | -19 | 13 | 13 | 206 | 98 | -35 | -88 | 181 | 184 |
| Tax % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | 27% | -0% | -0% | 12% | 25% |
| Net Profit + | -8 | 5 | 157 | -19 | 13 | 13 | 206 | 71 | -35 | -88 | 159 | 138 |
| EPS in Rs | 0.07 | 1.13 | 0.39 | -0.19 | -0.47 | 0.86 | 0.75 | |||||
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome